Today: 9 April 2026
IonQ stock jumps nearly 22% after results; 2026 revenue outlook and SkyWater deal in focus

IonQ stock jumps nearly 22% after results; 2026 revenue outlook and SkyWater deal in focus

New York, February 27, 2026, 07:27 EST — Premarket

IonQ surged 21.7% to finish at $40.88 on Thursday after its fourth-quarter numbers and 2026 revenue outlook beat forecasts. Shares changed hands at a brisk pace—volume reached 66.4 million, well past the stock’s three-month norm. Some smaller quantum names edged higher too, but their gains didn’t match IonQ’s. Nasdaq

This shift is notable; quantum computing stocks aren’t moving on lab progress anymore, but on whether companies can actually show “real revenue.” Cash burn gets hit hard by investors. Still, they’re willing to pay for growth that seems like it can last.

IonQ stands out as one of the rare public players in the sector handing investors both a straightforward quarterly report and a sales outlook. Like it or not, others in the group often end up following its lead.

IonQ posted $61.9 million in revenue for the fourth quarter, bringing full-year 2025 revenue to $130.0 million. Looking ahead, the company expects 2026 revenue to land between $225 million and $245 million. Chairman and CEO Niccolo de Masi described 2025 as “a strategic and financial inflection point.” CFO and COO Inder Singh noted that commercial customers provided over 60% of this year’s revenue, with international sales contributing more than 30%. Cash and investments stood at $3.3 billion at the end of the year. IonQ

IonQ is targeting the launch of an “operational 256 qubit system” in the fourth quarter of 2026, executives told investors on the company’s earnings call, according to the transcript. In a quantum computer, a qubit acts as the core unit of information—think of it as the quantum version of a classical bit. Investing.com

The company flagged another Thursday announcement, saying it has rolled out tech for Romania’s National Quantum Communication Infrastructure—36 quantum-secured links now running across over 1,500 kilometers. In quantum key distribution (QKD), quantum phenomena transmit encryption keys, making any snooping attempts more obvious. IonQ

Wall Street took a split view after the numbers landed. Rosenblatt’s John McPeake is still bullish, sticking with his buy call and a $100 price target. DA Davidson’s Alexander Platt, on the other hand, stayed neutral and slashed his target to $35. Needham’s Quinn Bolton also dialed back, now seeing $65 as fair value, Benzinga reported. Benzinga

Yet risks linger, even after a blowout quarter. IonQ continues to project heavy losses. The intended SkyWater Technology deal introduces fresh hurdles—both execution and regulatory sign-off. And there’s still plenty of uncertainty in the market over how soon quantum computing shifts from pilot projects to full-scale, recurring use.

Investors are watching for possible changes in management’s outlook on demand and deal flow when IonQ takes the stage at the Morgan Stanley Technology, Media & Telecom Conference on March 4, followed by the Cantor Global Technology & Industrial Growth Conference on March 11. businesswire.com

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:15 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Intel stock price: INTC set for a tense open after SambaNova AI deal, as chip nerves linger
Previous Story

Intel stock price: INTC set for a tense open after SambaNova AI deal, as chip nerves linger

SoFi stock slips in premarket as inflation data looms — what investors are watching next
Next Story

SoFi stock slips in premarket as inflation data looms — what investors are watching next

Go toTop